In wake of Reata buyout, Biogen’s key launch Skyclarys passes muster in EU fkansteiner Mon, 02/12/2024 – 16:57 More: In wake of Reata buyout, Biogen's key launch Skyclarys passes muster in EU Source: fierce
read moreFool me thrice: FDA blasts Chinese API maker for ‘misleading’ investigators, making up testing records fkansteiner Mon, 02/12/2024 – 14:29 More: Fool me thrice: FDA blasts Chinese API maker for 'misleading' investigators, making up testing records Source: fierce
read moreAstraZeneca ‘body checks’ cancer in NHL-partnered screening push ntaylor Mon, 02/12/2024 – 11:36 More: AstraZeneca ‘body checks’ cancer in NHL-partnered screening push Source: fierce
read moreGritstone’s BARDA-funded COVID vaccine faces manufacturing-related trial delay zbecker Mon, 02/12/2024 – 10:58 More: Gritstone's BARDA-funded COVID vaccine faces manufacturing-related trial delay Source: fierce
read moreIn stunning reversal, Takeda snags FDA approval for once-snubbed Eohilia after ‘significant grassroots support’ aliu Mon, 02/12/2024 – 10:52 More: In stunning reversal, Takeda snags FDA approval for once-snubbed Eohilia after ‘significant grassroots support’ Source: fierce
read moreThe platform delivers digitalised patient data to improve clinical trials and development More: Phesi’s AI-driven Trial Accelerator platform contains over 100 million patients Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals